SBIR/STTR Research Award

Magnetic Duodeno Ileal Bypass for Metabolic Syndrome in Rhesus Monkeys

Award identifier 313af75cd58442b74d750e324d3b1f327a940043d44ca76d79420f106d587c5fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$829,853

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MAGNAMOSIS INC
Proposal award date
2017-06-01
Contract end date
2019-05-31
UEI
YCTCHGENNMU1
Solicitation number
PAR14-088
Topic code
300

Research abstract

Project Summary Abstract Type diabetes mellitus T DM associated with obesity can now be successfully treated by bariatric surgery The metabolic effect is rapid in part independent of the effect on weight loss and mediated by gut factors We are exploring the possibility that this beneficial effect on T DM can be achieved without major surgery by creating a small side to side magnetic compression anastomosis between the duodenum and the ileum Magnetic Duodenal Ileal Bypass or DIPASS Our preliminary data in mini pigs suggest that by diverting a small amount of digestive juices gastric biliary pancreatic to the ileal mucosa this intestinal short cut is able to mimic the beneficial metabolic and hormonal effect of bypass surgeries on glucose metabolism This proposal will test the feasibility of inserting the intestinal short cut DIPASS in a non human primate model of metabolic syndrome the efficacy of the DIPASS procedure versus sham operation on improving metabolism and the mechanism by which DIPASS exerts its effect on glucose metabolism We will also collect a unique biobank of tissue samples that will allow further studies to assess the molecular mechanism by which the procedure exerts its effect DIPASS can be accomplished minimally invasively as an outpatient procedure using our previously developed magnetic anastomosis device Magnamosis and newly developed trans oral delivery devices that enable an incisionless procedure Data generated from this proposal will have direct translational application and will enable us to develop future studies in humans Project Narrative Type diabetes is a major public health problem approaching epidemic proportions in the U S and globally Growing evidence shows that type diabetes may be successfully treated by obesity surgery This project aims to demonstrate the feasibility and efficacy of reversing type diabetes through a novel minimally invasive outpatient surgical procedure utilizing some of the aspects of obesity surgery However our procedure is not a replacement bariatric surgery but rather a short procedure that repositions a portion of the small intestine causing a reversal of certain elements that contribute to type diabetes It is in no way intended to treat obesity

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.